Genpact Balance Sheet Analysis From 2010 to 2024
G Stock | USD 30.89 0.33 1.08% |
Genpact |
Most indicators from Genpact's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Genpact Limited current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Genpact Valuation and Genpact Correlation analysis. The Genpact's current Sales General And Administrative To Revenue is estimated to increase to 0.26, while Selling General Administrative is projected to decrease to roughly 576 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.4B | 1.5B | 1.6B | 902.8M | Total Revenue | 4.0B | 4.4B | 4.5B | 2.4B |
Genpact fundamental ratios Correlations
Click cells to compare fundamentals
Genpact Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Genpact fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.5B | 4.9B | 5.0B | 4.6B | 4.8B | 3.1B | |
Net Debt | 1.3B | 1.3B | 1.1B | 1.0B | 919.3M | 965.3M | |
Retained Earnings | 648.7M | 741.7M | 732.5M | 780.0M | 1.1B | 1.1B | |
Cash | 467.1M | 680.4M | 899.5M | 646.8M | 583.7M | 449.6M | |
Other Assets | 478.8M | 961.1M | 667.3M | 439.6M | 1.0 | 0.95 | |
Total Liab | 2.8B | 3.0B | 3.1B | 2.8B | 2.6B | 1.6B | |
Total Current Assets | 1.6B | 1.7B | 1.9B | 1.8B | 1.9B | 1.2B | |
Other Current Liab | 629.7M | 694.0M | 678.2M | 675.7M | 674.4M | 470.9M | |
Other Liab | 192.2M | 239.9M | 249.2M | 208.0M | 239.2M | 192.5M | |
Accounts Payable | 22.0M | 13.9M | 25.0M | 35.8M | 27.7M | 20.2M | |
Long Term Debt | 1.3B | 1.3B | 1.3B | 1.2B | 824.7M | 690.1M | |
Net Receivables | 914.3M | 881.0M | 887.7M | 994.8M | 1.1B | 613.1M | |
Good Will | 1.6B | 1.7B | 1.7B | 1.7B | 1.7B | 1.2B | |
Inventory | 121.2M | 150.1M | 103.7M | 1.0 | 1.15 | 1.09 | |
Other Current Assets | 49.2M | 37.3M | 30.7M | 138.0M | 169.0M | 177.5M | |
Short Term Debt | 161.2M | 340.0M | 445.0M | 231.2M | 503.4M | 528.6M | |
Intangible Assets | 230.9M | 236.7M | 169.6M | 89.7M | 53.0M | 50.4M | |
Common Stock | 1.9M | 1.9M | 1.8M | 1.8M | 1.8M | 2.5M | |
Net Tangible Assets | (116.2M) | (98.2M) | (3.5M) | 52.2M | 47.0M | 44.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Genpact Valuation and Genpact Correlation analysis. Note that the Genpact Limited information on this page should be used as a complementary analysis to other Genpact's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Complementary Tools for Genpact Stock analysis
When running Genpact's price analysis, check to measure Genpact's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genpact is operating at the current time. Most of Genpact's value examination focuses on studying past and present price action to predict the probability of Genpact's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genpact's price. Additionally, you may evaluate how the addition of Genpact to your portfolios can decrease your overall portfolio volatility.
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Genpact's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Genpact. If investors know Genpact will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Genpact listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.311 | Dividend Share 0.55 | Earnings Share 3.41 | Revenue Per Share 24.552 | Quarterly Revenue Growth 0.04 |
The market value of Genpact Limited is measured differently than its book value, which is the value of Genpact that is recorded on the company's balance sheet. Investors also form their own opinion of Genpact's value that differs from its market value or its book value, called intrinsic value, which is Genpact's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Genpact's market value can be influenced by many factors that don't directly affect Genpact's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Genpact's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genpact is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genpact's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.